Selcuk Erdem

25PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)AnaesthesiologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 29, 2026
The expression and prognostic significance of immune checkpoint molecules across clear cell, papillary and chromophobe renal cell carcinoma subtypes.

|Aug 29, 2026
The effect of toll like receptors in prognosis in patients undergoing radical cystectomy for bladder cancer.

|Aug 24, 2026
Outcomes of [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study.

|Jul 02, 2026
Does WHO/ISUP grade IV histology provide prognostic insight in chromophobe renal cell carcinoma?

|Jun 29, 2026
What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.

|Jun 12, 2026
ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates.

Pageof 5

Frequent Collaborators

7 joint publications

Riccardo Campi

7 joint publications

Öner Şanlı

5 joint publications

Nicola Pavan

5 joint publications

Riccardo Bertolo